Bintie Biotechnology
Pudong
About Bintie Biotechnology
Bintie Biotechnology is a pioneering biomedical technology enterprise in the clinical stage. Its primary products are novel immune cell formulations intended to target solid tumors.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $13.7M
- Funding stage: Early Stage Venture
- Last round: Series A (Oct 2023)
- Website: immuxell.cn
- Phone: 021-58256952
Industries & Categories
Biotechnology, Medical, Product Research
Canonical: https://fsome.com/organization/bintie-biotechnology-36467 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.